Savient Pharms Drug Patent Portfolio
Savient Pharms owns 1 orange book drug protected by 5 US patents Given below is the list of Savient Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5872147 | Use of oxandrolone in the treatment of chronic obstructive pulmonary disease | 05 Dec, 2017 | Expired |
| US6576659 | Use of oxandrolone in the treatment of burns an other wounds | 05 Dec, 2017 | Expired |
| US6828313 | Use of oxandrolone in the treatment of burns and other wounds | 05 Dec, 2017 | Expired |
| US6090799 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 | 18 Jul, 2017 | Expired |
| US6670351 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 | 20 Oct, 2012 | Expired |
Latest Legal Activities on Savient Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Savient Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Correspondence Address Change
Critical
| 23 Dec, 2008 | US6828313 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Dec, 2004 | US6828313 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Dec, 2004 | US6828313 |
|
Issue Notification Mailed
Critical
| 18 Nov, 2004 | US6828313 |
| Dispatch to FDC | 27 Oct, 2004 | US6828313 |
|
Issue Fee Payment Received
Critical
| 19 Oct, 2004 | US6828313 |
|
Issue Fee Payment Verified
Critical
| 19 Oct, 2004 | US6828313 |
| Reverse Issue Fee | 19 Oct, 2004 | US6828313 |
|
Mail Notice of Allowance
Critical
| 18 Oct, 2004 | US6828313 |
|
Notice of Allowance Data Verification Completed
Critical
| 15 Oct, 2004 | US6828313 |
|
Case Docketed to Examiner in GAU
Critical
| 01 Oct, 2004 | US6828313 |
| Date Forwarded to Examiner | 30 Aug, 2004 | US6828313 |
| Workflow incoming amendment IFW | 19 Aug, 2004 | US6828313 |
|
Response after Non-Final Action
Critical
| 19 Aug, 2004 | US6828313 |
|
Information Disclosure Statement (IDS) Filed
Critical
| 19 Aug, 2004 | US6828313 |
Savient Pharms's Family Patents
Savient Pharms Drug List
Given below is the complete list of Savient Pharms's drugs and the patents protecting them.
1. Oxandrin
Oxandrin is protected by 5 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5872147 | Use of oxandrolone in the treatment of chronic obstructive pulmonary disease |
05 Dec, 2017
(7 years ago)
| Expired |
| US6576659 | Use of oxandrolone in the treatment of burns an other wounds |
05 Dec, 2017
(7 years ago)
| Expired |
| US6828313 | Use of oxandrolone in the treatment of burns and other wounds |
05 Dec, 2017
(7 years ago)
| Expired |
| US6090799 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
18 Jul, 2017
(8 years ago)
| Expired |
| US6670351 | Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1 |
20 Oct, 2012
(13 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oxandrin's drug page